ProjectAtlas-Studie – Efficacy, Safety, and Pharmacokinetic Profile of ANB020 in Adults with Moderate-to-Severe Atopic…

Basic data

Acronym:
Atlas-Studie
Title:
Efficacy, Safety, and Pharmacokinetic Profile of ANB020 in Adults with Moderate-to-Severe Atopic Dermatitis
Duration:
01/09/2018 to 31/12/2019
Abstract / short description:
Protocol Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study
Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects
with Moderate-to-Severe Atopic Dermatitis
Keywords:
atopic dermatitis
Atopische Dermatitis

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

San Diego, Kalifornien, United States
Help

will be deleted permanently. This cannot be undone.